Hims CEO says he'd rather go af­ter ri­val­s' cus­tomers than buy their busi­ness­es

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

SAN FRAN­CIS­CO — For com­pa­nies that ad­ver­tise health­care ser­vices rang­ing from hair loss treat­ments to on­line ther­a­py di­rect­ly to con­sumers, it’s been ex­pen­sive in the last few years to at­tract new cus­tomers.

While there are still pre­dic­tions that the dig­i­tal di­rect-to-con­sumer in­dus­try might con­sol­i­date, as some in­dus­try ex­perts are ex­pect­ing this year, Hims & Hers though, one of the few pub­licly trad­ed dig­i­tal health com­pa­nies, like­ly won’t be among the ac­quir­ers, its CEO told End­points News on a re­cent vis­it to San Fran­cis­co, where the com­pa­ny is head­quar­tered.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER